Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 5 of 5 for “"Ganetespib"”.
-
Novel approach to cancer therapeutics using comparative cancer biology
… focused on the effect of the HSP90-inhibitor Ganetespib had on its client proteins, particularly IRF-1. Briefly my results indicated the following:(i) Ganetespib downregulated IRF-1 protein levels in A375 cell lines and this attenuation was not mediated by either MDM2 or CHIP (E3 ligase). …
-
Enhancing Radiation Sensitivity In Non-Small Cell Lung Cancer
… the potent and clinically relevant inhibitors ganetespib and trametinib. Using both in vitro experiments in multiple non-small cell lung cancer (NSCLC) cell lines and in vivo experiments in animal models, I tested the ability of these inhibitors to radiosensitize lung tumors in the clinically …
-
Developing Novel Approaches to Improve Response to T Cell Based Cancer Immunotherapy
… We show that treatment with the HSP90 inhibitor ganetespib (Synta) greatly improves T cell mediated cytotoxicity of both human and murine cancer cells lines in vitro. Furthermore, in vivo murine studies using the MC38/gp100 tumour model show that ganestespib in combination with immune checkpoint …
-
THE ROLE OF THE MECHANICAL PROPERTIES OF THE EXTRACELLULAR MATRIX IN CILIOGENESIS
… of ECM cross-linking degree. The performance of ganetespib, a common cancer therapeutic and HSP90 inhibitor, shows a decrease in efficacy on substrate with high degree of cross-linking.
-
Genome-scale Precision Proteomics Identifies Cancer Signaling Networks and Therapeutic Vulnerabilities
… concentrations of an HSP90 inhibitor (ganetespib) in combination with conventional chemotherapy used for recurrent RMS. These effects were seen in the most aggressive recurrent RMS orthotopic patient derived xenografts irrespective of RAS pathway perturbations, histologic or molecular …